Vanda Pharmaceuticals | VNDA - القيمة السوقية





القيمة السوقية تغيير تاريخ
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
Akebia Therapeutics USD 427M 297M 2025-12
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 10.84B 664M 2026-08
AstraZeneca USD 178.16B 111.83B 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Eli Lilly USD 1.11T 18.32B 2026-08
Enanta Pharmaceuticals USD 122M 98M 2024-12
Halozyme Therapeutics USD 10.91B 1.63B 2026-08
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 19.68B 3.43B 2026-08
J&J USD 611.36B 32.21B 2026-06
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Ligand Pharmaceuticals USD 5.31B 1.02B 2026-08
Merck USD 324.18B 6.81B 2026-08
Novartis USD 288.26B 25.18B 2026-03
Pfizer USD 153.17B 14.73B 2026-08
Sanofi EUR 91.15B 9.12B 2026-06
Takeda JPY 8.2T 809.7B 2026-06
Teva Pharmaceutical Industries USD 114.54B 80.27B 2026-06
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Vanda Pharmaceuticals USD 279M 6M 2024-12
Veracyte USD 4.69B 2.12B 2026-06